Julie Waras Brogren
Director Financiero/CFO en ASCELIA PHARMA AB .
Fortuna: 59 016 $ al 31/05/2024
Perfil
Julie Waras Brogren is currently the Deputy CEO-Finance & Investor Relations at Ascelia Pharma AB.
She is also a Director at Ossiform ApS and Pila Pharma AB.
Previously, she worked as a Senior Director-Launch Office at Novo Nordisk A and as the President of Bresotec, Inc. from 2017 to 2019.
Ms. Brogren holds a graduate degree from Copenhagen Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ASCELIA PHARMA AB
0.17% | 13/07/2023 | 59 000 ( 0.17% ) | 59 016 $ | 31/05/2024 |
Cargos activos de Julie Waras Brogren
| Empresas | Cargo | Inicio |
|---|---|---|
| ASCELIA PHARMA AB | Director Financiero/CFO | 01/01/2023 |
| PILA PHARMA AB | Director/Miembro de la Junta | 01/04/2024 |
Ossiform ApS
 Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Julie Waras Brogren.
| Empresas | Cargo | Fin |
|---|---|---|
| Bresotec, Inc. | Presidente | 01/06/2019 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formación de Julie Waras Brogren.
| Copenhagen Business School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| PILA PHARMA AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ossiform ApS
Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Commercial Services |
| Bresotec, Inc. |
- Bolsa de valores
- Insiders
- Julie Waras Brogren
